Physician profile
Mark Zieba
NPI 1578781647
$2,434.30
in general payments reported to CMS, 2019-2025
12 companies · $17.41 in 2025
The $17.41 reported for 2025 was less than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $160 · 2020: $1,340 · 2021: $182 · 2022: $422 · 2023: $162 · 2024: $150 · 2025: $17.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $199 · Gift: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.86 |
| Gift | $130.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Patterson Companies, INC. | $1,342.50 | 2020-2022 | |
| Henry Schein, INC. | $247.49 | 2022 | |
| Kulzer, LLC | $191.42 | 2019-2020 | |
| Zimvie INC. | $146.13 | 2023 | |
| Align Technology, INC. | $142.17 | 2021-2022 | |
| Ultradent Products INC | $130.98 | 2024 | Opalescence |
| A-Dec, INC. | $116.50 | 2019 | |
| Dentsply Sirona INC | $49.36 | 2022-2025 | Suresmile, Midwest E Plus |
| Biohorizons Implant Systems INC. | $28.27 | 2022 | |
| Elevate Oral Care | $19.00 | 2024 | Fluorimax Mint, Advantage Arrest, Just Right 5000 |
| Gc America INC. | $12.66 | 2022 | |
| Coltene Whaledent INC. | $7.82 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Zieba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.